相关实验视频
Updated: Jun 27, 2025
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.0K
提-1 限制了脂肪和肝纤维化在脂肪性肝病中的肝硬化
Valentin Blank1,2, Thomas Karlas1, Ulf Anderegg3
1Division of Gastroenterology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.
概括
胸细胞分化抗原 (Thy-1) 保护小鼠免受脂肪肝疾病和纤维化发展. 较低的血清溶解Thy-1 (sThy-1) 水平与患者的肝纤维化相关,这表明Thy-1是一种保护因素.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 肥胖性肝病 (SLD) 从肥胖症发展为纤维化和肝硬化,由代谢综合征驱动.
- 了解SLD的病原体是开发新疗法的关键.
- 胸细胞分化抗原 (Thy-1) 影响纤维细胞的功能,对纤维生成至关重要.
研究的目的:
- 研究Thy-1在高脂肪饮食引起的SLD和纤维化中的作用.
- 在与代谢功能障碍相关的SLD患者中分析血清溶解的Thy-1 (sThy-1).
- 确定Thy-1是否作为SLD和纤维化病的保护因素.
主要方法:
- 使用野生型和Thy-1-缺乏的小鼠食高脂肪饮食 (HFD) 来建模SLD.
- 评估与纤维化相关的肝病理和基因表达.
- 使用非侵入性纤维化标志物测量SLD患者的血清sthy-1度.
主要成果:
- 在HFD养小鼠中,thy-1减弱脂肪肝的发展和益菌原基因表达.
- Thy-1 直接抑制了非帕伦基马性肝细胞的益菌性激活.
- Thy-1 预防了棕酸诱导的髓状细胞炎症,减少了缺陷小鼠中的纤维化.
- 血清sThy-1水平与SLD患者的肝纤维化状态相关.
结论:
- 在小鼠模型和人类SLD中,Thy-1充当显著的纤维化保护因子.
- 提-1可能是缓解SLD进展的治疗标.
- sThy-1水平可以作为SLD肝纤维化的非侵入性生物标志物.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
6.3K
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
876
相关概念视频
01:24Liver Regeneration
3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
01:30Liver Physiology
518
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
518